Dr. Hendrik Luesch presents at the 7th Kuwait International Pharmacy Conference
Luesch presented on the expanding chemical space for drug discovery at the conference in Kuwait City.
Luesch presented on the expanding chemical space for drug discovery at the conference in Kuwait City.
The grant will bolster research on Mitragyna speciosia, or kratom, and its potential to treat opioid misuse and physical dependence.
UF researchers discovered their compounds induced rapid iron starvation through a series of experiments using novel compounds known as halogenated phenazines, or HPs.
New research reveals two common naloxone products remain chemically stable after their expiration dates.
The 10 medicinal chemistry faculty currently serve as principal investigators on 18 different federally funded grants worth more than $18.4 million.
A UF College of Pharmacy researcher team led by Dr. Hendrik Luesch recently developed a novel molecule based on marine cyanobacteria, Apra S10, to target pancreatic cancer cells.
With the funding from the Maximizing Investigators’ Research Award, Ding aims to access and expand chemical diversity of microbes through the use of new, innovative strategies.
Known as the Maximizing Investigators’ Research Award, the grant will fund several of Huigens’ research projects, including efforts to develop compounds that will eliminate bacterial biofilm-associated infections.
Led by principal investigator, Rob Huigens, Ph.D., an assistant professor of medicinal chemistry, the grant aims to establish a drug discovery pipeline to generate and identify new small molecules that possess anticancer activities.
Cisneros' poster ranked in the top 25 percent of all TL1 trainees presenting at the Association for Clinical and Translational Science Meeting.